Characteristics of clinical trials of new oncology drugs approved in China.

Published in: Cancer (2023)

By presenting a multidimensional landscape of clinical trials and approvals in the real world, this review allows interested researchers, developers, and even regulators to understand what has been done and what should be done next in anticancer drug development in China.

Keyphrases

clinical trial
palliative care
phase ii
transcription factor
case report
randomized controlled trial
open label
study protocol
double blind